MACOM Technology Solutions Holdings, Inc. filings document the formal reporting record for a Nasdaq-listed semiconductor manufacturer serving Industrial and Defense, Data Center and Telecommunications markets. The company’s 8-K reports include results of operations and financial condition, with exhibits furnishing quarterly and annual earnings releases and related GAAP and non-GAAP financial measures.
MACOM’s proxy and governance filings cover annual meeting matters, director elections, advisory executive compensation votes, auditor ratification and stockholder voting results. Additional current reports document board composition, executive officer appointments, compensation arrangements and director departures, connecting corporate governance disclosures with the company’s semiconductor operating structure.
MACOM Technology Solutions (NASDAQ:MTSI) filed a Form 4 indicating that SVP Operations Robert Dennehy sold 5,000 common shares on 24 June 2025 at a weighted-average $140.42, generating roughly $0.7 million in proceeds. The sale was executed under a Rule 10b5-1 plan adopted 28 Feb 2025 and reduced the insider’s direct ownership to 15,680 shares, a decline of about 24 %. No derivative transactions were reported.
MACOM Technology Solutions (NASDAQ:MTSI) filed a Form 4 reporting that Director and 10% owner Susan Ocampo made a gift of 200,000 common shares on June 24 2025 to a charitable donor-advised fund at a stated price of $0, indicating no pecuniary interest was retained.
After the transfer, Ocampo still beneficially owns 10,235,575 shares indirectly—4,615,331 through the Ocampo Family Trust, 4,118,621 via six trusts for her children, and 1,500,000 through a GRAT—plus 1,623 shares directly. No open-market sales, purchases, or Rule 10b5-1 trading plans were disclosed.
The transaction reduces her total holdings by roughly 2% and appears to be a routine philanthropic move rather than a signal of changed investment or control intentions.
MACOM Technology Solutions Holdings, Inc. (ticker MTSI) filed a Form 144 indicating a proposed insider sale of 5,000 common shares. The seller, identified in related 10b5-1 data as Robert Dennehy, plans to execute the transaction through Morgan Stanley Smith Barney LLC on or about 24 June 2025. The shares were originally acquired on 27 October 2021 via Performance Stock Units and will be sold under an existing 10b5-1 trading plan, limiting the risk of information-based timing.
The filing assigns an aggregate market value of $693,250, implying a per-share price near $138.65. Relative to MACOM’s 74.39 million shares outstanding, the proposed sale represents approximately 0.0067 % of total shares, a de-minimis dilution and cash realization. Over the prior three months, the same insider executed another 10b5-1 sale of 4,113 shares for gross proceeds of $497,943, bringing disclosed recent disposals to 9,113 shares worth roughly $1.19 million.
Form 144 filings are routine advance notices rather than completed transactions; they can signal insider sentiment but rarely move markets unless volumes are large. The limited size and the structured 10b5-1 framework suggest minimal immediate impact on the company’s capital structure or liquidity. Investors may, however, monitor cumulative insider activity for trend analysis.